Consnesus $1.06B. Raises FY25 adjusted EBITDA view to $420M-$428M from $417M-$427M. “The integration of EvolutionIQ is proceeding on plan and the expected launch of Medhub for Casualty is ahead of schedule. We intend for this to be the first of many new solutions that provide AI-powered synthesis and best next action recommendations based on insurer preferences to enhance insurers’ ability to consistently manage increasingly complex injury claims and achieve better outcomes,” continued Ramamurthy. “We view this as an important step in accelerating our vision of deploying intelligent experiences across the insurance economy.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCCS:
- CCC Intelligent Solutions reports Q1 adjusted EPS 8c, consensus 8c
- Ccc Intelligent Solutions Holdings Inc (CCCS) Q1 Earnings Cheat Sheet
- Positive Outlook for CCC Intelligent Solutions Holdings: Buy Rating Affirmed Amid Growth Potential and Attractive Valuation
- CCC Intelligent Solutions price target lowered to $13 from $15 at Morgan Stanley
- CCC Intelligent Solutions price target lowered to $11 from $13 at Barclays